Arvinas Competitors and Similar CompaniesClear all
Arvinas's competitors and similar companies include Agenus.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New Haven, US HQ | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US |
Employees | Employees 13329% increase | Employees 38927% decrease |
Valuation ($) | Valuation ($) 1.7 b | Valuation ($) 134.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $78.5m (FY, 2023) | Revenue (est.) $156.3m (FY, 2023) |
Net income | Net income ($367.3m) (FY, 2023) | Net income ($257.4m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 111.6m | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
Agenus
HQ
Lexington, US
Employees
389↓ 27% decrease
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company